1. 2022
  2. Targeted proteomics improves cardiovascular risk prediction in secondary prevention

    Nurmohamed, N. S., Belo Pereira, J. P., Hoogeveen, R. M., Kroon, J., Kraaijenhof, J. M., Waissi, F., Timmerman, N., Bom, M. J., Hoefer, I. E., Knaapen, P., Catapano, A. L., Koenig, W., de Kleijn, D., Visseren, F. L. J., Levin, E. & Stroes, E. S. G., 21 Apr 2022, In: European heart journal. 43, 16, p. 1569-1577 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apnea

    Kaiser, Y., Dzobo, K. E., Ravesloot, M. J. L., Nurmohamed, N. S., Collard, D., Hoogeveen, R. M., Verberne, H. J., Dijkstra, N., de Vries, N., Bresser, P., Kroon, J., Stroes, E. S. G. & Reesink, H. J., 1 Mar 2022, In: Atherosclerosis. 344, p. 7-12 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. The challenge of choosing in cardiovascular risk management

    PANORAMA working group, Jan 2022, In: Netherlands heart journal. 30, 1, p. 47-57 11 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. 2021
  6. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease

    Hoogeveen, R. M., Verweij, S. L., Kaiser, Y., Kroon, J., Verberne, H. J., Vogt, L., Moens, S. J. B. & Stroes, E. S. G., 1 Dec 2021, In: Scientific reports. 11, 1, 4126.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. From targeting major cardiovascular players to precision medicine

    Hoogeveen, R. M., 2021, 277 p.

    Research output: PhD ThesisPhd-Thesis - Research and graduation internal

  8. 2020
  9. Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy

    Opstal, T. S. J., Hoogeveen, R. M., Fiolet, A. T. L., Silvis, M. J. M., The, S. H. K., Bax, W. A., de Kleijn, D. P. V., Mosterd, A., Stroes, E. S. G. & Cornel, J. H., 17 Nov 2020, In: Circulation. 142, 20, p. 1996-1998 3 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  10. Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

    Hoogeveen, R. M., Pereira, J. P. B., Nurmohamed, N. S., Zampoleri, V., Bom, M. J., Baragetti, A., Boekholdt, S. M., Knaapen, P., Khaw, K-T., Wareham, N. J., Groen, A. K., Catapano, A. L., Koenig, W., Levin, E. & Stroes, E. S. G., 1 Nov 2020, In: European heart journal. 41, 41, p. 3998-4007 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Anti-inflammatoire therapie bij hart- en vaatziekten

    Hoogeveen, R. M., Stroes, E. S. G. & Cornel, J. H., 1 Oct 2020, In: Nederlands tijdschrift voor geneeskunde. 164, 44, D4697.

    Research output: Contribution to journalArticleProfessional

  12. Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy

    Waissi, F., Dekker, M., Timmerman, N., Hoogeveen, R. M., van Bennekom, J., Dzobo, K. E., Schnitzler, J. G., Pasterkamp, G., Grobbee, D. E., de Borst, G. J., Stroes, E. S. G., de Kleijn, D. P. V. & Kroon, J., 1 Oct 2020, In: Stroke; a journal of cerebral circulation. 51, 10, p. 2972-2982 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 Next

ID: 111090